Correction to: Is the Availability of Biosimilar Adalimumab Associated with Budget Saving? A Difference-in-Difference Analysis of 14 Countries

Saved in:
Bibliographic Details
Published in:BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy biopharmaceuticals, and gene therapy, 2024-03, Vol.38 (2), p.323-323
Main Authors: Woo, Hyunjung, Shin, Gyeongseon, Lee, Donghwan, Kwon, Hye-Young, Bae, SeungJin
Format: Article
Language:English
Subjects:
Antibodies
Biomedical and Life Sciences
Biomedicine
Cancer Research
Correction
Molecular Medicine
Pharmacotherapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1173-8804
1179-190X
DOI:10.1007/s40259-024-00645-6